Segment Information by Division
January 1 to December 31
Download XLS |
|
|
|||||||||||||||||||
€ million |
Silicones |
Polymers |
Biosolutions |
Polysilicon |
Siltronic |
Other |
Consolidation |
Group |
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
|
||||||||||||||||||||
2016 |
|
|
|
|
|
|
|
|
||||||||||||
External sales |
2,001.0 |
1,176.4 |
206.4 |
1,008.7 |
928.3 |
83.4 |
– |
5,404.2 |
||||||||||||
Internal sales |
0.1 |
18.4 |
– |
86.8 |
5.1 |
79.2 |
-189.6 |
– |
||||||||||||
Total sales |
2,001.1 |
1,194.8 |
206.4 |
1,095.5 |
933.4 |
162.6 |
-189.6 |
5,404.2 |
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
EBIT |
280.8 |
223.7 |
25.7 |
-117.1 |
28.7 |
-76.0 |
0.4 |
366.2 |
||||||||||||
Depreciation and impairments, and write-ups |
80.4 |
37.3 |
11.3 |
403.0 |
117.2 |
86.2 |
-0.2 |
735.2 |
||||||||||||
EBITDA |
361.2 |
261.0 |
37.0 |
285.9 |
145.9 |
10.2 |
0.2 |
1,101.4 |
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
EBIT includes: |
|
|
|
|
|
|
|
|
||||||||||||
Impairment of fixed assets |
– |
– |
– |
-2.5 |
-0.9 |
– |
– |
-3.4 |
||||||||||||
Result from investments in joint ventures and associates |
0.2 |
– |
– |
– |
– |
– |
– |
0.2 |
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
Asset additions1 |
88.6 |
37.5 |
9.1 |
130.0 |
89.5 |
72.9 |
– |
427.6 |
||||||||||||
Change in the scope of consolidation |
26.1 |
– |
11.2 |
– |
– |
– |
– |
37.3 |
||||||||||||
Total asset additions |
114.7 |
37.5 |
20.3 |
130.0 |
89.5 |
72.9 |
– |
464.9 |
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
Assets (Dec. 31) |
1,379.8 |
580.2 |
151.9 |
3,018.1 |
1,034.4 |
1,326.9 |
-29.7 |
7,461.6 |
||||||||||||
Liabilities (Dec. 31) |
851.8 |
291.2 |
70.9 |
1,168.1 |
631.4 |
1,879.5 |
-24.5 |
4,868.4 |
||||||||||||
Net assets (Dec. 31) |
528.0 |
289.0 |
81.0 |
1,850.0 |
403.0 |
-552.6 |
-5.2 |
2,593.2 |
||||||||||||
Investments in joint ventures and associates included in net assets (Dec. 31) |
11.2 |
– |
– |
– |
– |
– |
– |
11.2 |
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
Research and development expenses |
37.9 |
17.5 |
6.2 |
16.9 |
66.5 |
41.4 |
-3.0 |
183.4 |
||||||||||||
Employees (Dec. 31) |
4,566 |
1,484 |
510 |
2,490 |
3,757 |
4,398 |
– |
17,205 |
||||||||||||
Employees (average) |
4,468 |
1,480 |
508 |
2,448 |
3,811 |
4,403 |
– |
17,118 |
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
2015 |
|
|
|
|
|
|
|
|
||||||||||||
External sales |
1,942.8 |
1,162.5 |
197.1 |
978.9 |
923.8 |
91.1 |
– |
5,296.2 |
||||||||||||
Internal sales |
0.5 |
23.0 |
– |
84.7 |
7.5 |
106.4 |
-222.1 |
– |
||||||||||||
Total sales |
1,943.3 |
1,185.5 |
197.1 |
1,063.6 |
931.3 |
197.5 |
-222.1 |
5,296.2 |
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
EBIT |
194.5 |
184.4 |
21.0 |
162.6 |
4.5 |
-94.5 |
0.9 |
473.4 |
||||||||||||
Depreciation and impairments, and write-ups |
81.7 |
37.8 |
11.2 |
239.8 |
119.5 |
85.6 |
-0.2 |
575.4 |
||||||||||||
EBITDA |
276.2 |
222.2 |
32.2 |
402.4 |
124.0 |
-8.9 |
0.7 |
1,048.8 |
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
EBIT includes: |
|
|
|
|
|
|
|
|
||||||||||||
Income from investments in joint ventures and associates |
3.3 |
– |
– |
– |
– |
– |
– |
3.3 |
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
Asset additions1 |
82.0 |
47.4 |
6.2 |
581.8 |
75.1 |
41.5 |
– |
834.0 |
||||||||||||
Asset additions |
82.0 |
47.4 |
6.2 |
581.8 |
75.1 |
41.5 |
– |
834.0 |
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
Assets (Dec. 31) |
1,309.3 |
589.9 |
149.3 |
3,132.0 |
1,016.1 |
1,096.3 |
-28.5 |
7,264.4 |
||||||||||||
Liabilities (Dec. 31) |
749.0 |
281.1 |
67.0 |
1,392.0 |
543.5 |
1,451.5 |
-14.8 |
4,469.3 |
||||||||||||
Net assets (Dec. 31) |
560.3 |
308.8 |
82.3 |
1,740.0 |
472.6 |
-355.2 |
-13.7 |
2,795.1 |
||||||||||||
Investments in joint ventures and associates included in net assets (Dec. 31) |
21.2 |
– |
– |
– |
– |
– |
– |
21.2 |
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||||
Research and development expenses |
35.8 |
14.8 |
6.1 |
15.3 |
64.3 |
42.8 |
-3.8 |
175.3 |
||||||||||||
Employees (Dec. 31) |
4,353 |
1,461 |
491 |
2,373 |
3,894 |
4,400 |
– |
16,972 |
||||||||||||
Employees (average) |
4,348 |
1,442 |
491 |
2,278 |
4,004 |
4,374 |
– |
16,937 |